Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F White

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Schizophrenia Research|December 13, 2018
Hippocampal volume and vasculature before and after exercise in treatment-resistant schizophreniaM L Woodward, K M Gicas, D E Warburton, et al.
European Journal of Pharmacology|August 11, 2000
Characterisation of SB-221420-A - a neuronal Ca(2+) and Na(+) channel antagonist in experimental models of strokeC A Campbell, F C Barone, C D Benham, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemiaF C Barone, E A Irving, A M Ray, et al.
Physical Review Letters|December 13, 2006
Observation of muon neutrino disappearance with the MINOS detectors in the NuMI neutrino beamD G Michael, P Adamson, T Alexopoulos, et al.
Physical Review Letters|October 5, 2025
Measurement of Reactor Antineutrino Oscillation at SNOM Abreu, V Albanese, A Allega, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Schizophrenia Research|December 13, 2018
Hippocampal volume and vasculature before and after exercise in treatment-resistant schizophreniaM L Woodward, K M Gicas, D E Warburton, et al.
European Journal of Pharmacology|August 11, 2000
Characterisation of SB-221420-A - a neuronal Ca(2+) and Na(+) channel antagonist in experimental models of strokeC A Campbell, F C Barone, C D Benham, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemiaF C Barone, E A Irving, A M Ray, et al.
Physical Review Letters|December 13, 2006
Observation of muon neutrino disappearance with the MINOS detectors in the NuMI neutrino beamD G Michael, P Adamson, T Alexopoulos, et al.
Physical Review Letters|October 5, 2025
Measurement of Reactor Antineutrino Oscillation at SNOM Abreu, V Albanese, A Allega, et al.
Pageof 14